Skip to main content
Clinical Trials/NCT06164990
NCT06164990CompletedNot Applicable

Polyether Ketone Ketone (PEKK) Framework for Mandibular Implant-supported Complete Fixed Dental Prostheses With All-on-four Treatment Concept Clinical and Radiographic Study

Fatma mahanna1 site in 1 country16 target enrollmentStarted: May 10, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
16
Locations
1
Primary Endpoint
peri-implant probing depth

Study Overview

Brief Summary

This clinical study aims to evaluate the effect of using PEKK (Pekkton) framework in mandibular implant-supported complete fixed dental prostheses with All-on-four treatment concept on peri-implant tissues health

Detailed Description

The aim of this clinical study is to evaluate the effect of using PEKK (Pekkton) framework in mandibular implant-supported complete fixed dental prostheses with All-on-four treatment concept on peri-implant tissues health regarding the following parameters:

  • Modified Plaque index
  • Modified Gingival index
  • Peri-implant probing pocket depth

Radiographic evaluation (periapical x-ray):

Marginal bone height changes

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
50 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Maxillary and mandibular alveolar ridges were covered with healthy, firm, relatively even thickness and even compressible mucosa and free from any signs of inflammation or flabbiness.
  • •Patients had completely edentulous maxillary and mandibular ridges with sufficient mandibular bone height not less than 15 mm in the interforaminal area and at least 12mm posteriorly
  • •All patients had sufficient inter-arch space
  • •All patients complained of insufficient retention and stability of their conventional mandibular dentures.
  • •All patients were of Angel's class I maxillo-mandibular relationship.

Exclusion Criteria

  • •Patients with absolute contraindications for implant placement, such as active cancer and diseases of the immune system.
  • •Patients with metabolic diseases that are directly related to bone resorption, such as uncontrolled diabetes, osteoporosis, and hyperparathyroidism.
  • •Patients with general contraindications for surgical procedures, such as hematologic diseases, hepatic patients, patients with bleeding disorders, and serious problems with coagulation.
  • •Patients with a history of irradiation of the head and neck region or chemotherapy in the last 3 years were also excluded.
  • •Patients with relative contraindications such as a history of parafunctional habits (such as bruxism and clenching), smoking, alcoholism, and patients with any physical reasons that could affect follow-up.
  • •Patients with local contraindications for implant placement, such as localized bone defects.

Arms & Interventions

PEKK (Pekkton) framework

Experimental

PEKK (Pekkton) framework in mandibular implant-supported complete fixed dental prostheses with All-on-four treatment concept and evaluated regarding peri-implant tissue health

Intervention: PEKK framework (Other)

Outcomes

Primary Outcomes

peri-implant probing depth

Time Frame: 1 year

Probing depth using plastic periodontal probe

Peri-implant radiographic evaluation

Time Frame: 1 year

Marginal bone height changes using periapical radiograph

peri-implant tissues health (Clinical)

Time Frame: 1 year

Modified gingival index

modified plaque index

Time Frame: 1 year

peri-implant tissues health (Clinical)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Fatma mahanna
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Fatma mahanna

lecturer of prosthodontics

Mansoura University

Study Sites (1)

Loading locations...

Similar Trials